chrisvoncsefalvay/vaers-outcomes huggingface dataset:
About 20 minutes after receiving the shot, patient fainted. He gained consciousness after few seconds and was responsive. He reported no trouble breathing or any other reaction. he reported that he feels dizzy occasionally. EMS  was activated, Patient was able to stand up and walk on his own out of the store. He reported feeling completely fine and did not want to go to ER but just went with EMS to their van to get evaluated
2 patients received the Moderna Covid-19 vaccine 12 hours past it's beyond use date.; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (2 patients received the Moderna Covid-19 vaccine 12 hours past it's beyond use date.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In October 2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (2 patients received the Moderna Covid-19 vaccine 12 hours past it's beyond use date.). In October 2021, EXPIRED PRODUCT ADMINISTERED (2 patients received the Moderna Covid-19 vaccine 12 hours past it's beyond use date.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No Treatment informations were reported.
shortness of breath, tingling feeling in lip and face; shortness of breath, tingling feeling in lip and face; shortness of breath, tingling feeling in lip and face; This is a spontaneous report from a contactable other healthcare professional (HCP) who reported for herself. A 61-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) intramuscularly on 20Jan2021 at 14:45 (at the age of 61-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history included restless leg syndrome from an unspecified date and unspecified if ongoing. It was unknown whether the patient was diagnosed with COVID-19 prior to vaccination. Concomitant medications (received within 2 weeks of vaccination) included tretinoin (RETIN A; skin cream), biotin, vitamin D NOS, calcium and multivitamin, all taken for unspecified indications on unspecified dates. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient experienced shortness of breath, tingling feeling in lip and face, all on 20Jan2021, all reported as non-serious. The events did not cause hospitalization. No treatment was received for the events. The clinical outcomes of the events shortness of breath, tingling feeling in lip and face were all unknown. It was also reported that since the vaccination the patient had not been tested for COVID-19.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Narrative:  Pt is a 96y male. Died on 07/11/2021. Patients son called to report the passing. No other information was given. Vaccines unlikely to be linked to the cause of death. Patient received covid vaccines on 2/24/21 & 1/19/21.
I woke up at 3am on the 4/1 ,shivering so bad- I took my temperature it was 102.4. I was nervous about taking anything, because of what I heard. I took two Advil's and went down to 100. Around 10am the next morning it broke. I went to see my Doctor thought that my immune system over reacted to the vaccine as I haven't been out in a year or been sick, she wasn't too concerned about it. I've had some stomach issues- mild diarrhea and stomach pain. Not sure it has to do with the vaccine.
Tachycardia Narrative: Known history of atrial tachycardia, started as soon as received vaccine, observed in ED 30 minutes, no treatment required
This is a spontaneous report from a contactable pharmacist. A 67-year-old male patient received a singe dose of PREVNAR (Lot Number: J67643; Expiration Date: Mar2016; NDC Number: 0005-1971-02), via an unspecified route of administration on 06Jul2015 at 12:00. Medical history included diabetes and grouchiness on unknown dates. Concomitant medications included atenolol, folic acid, furosemide, gabapentin, NOVOLOG, LEVEMIR, levothyroxine, omeprazole, potassium, and trazodone. On 07Jul2015, the patient experienced extremely high blood glucose level. The patient underwent lab tests and procedures and included blood glucose which showed rise in blood glucose level on 07Jul2015 and 08Jul2015 he woke up with high reading. Pharmacist stated that the event did not require any emergency or doctor visit and further added that the patient had called doctor for something and no other vaccine was given on the same day as well as four weeks prior to the adverse event. The clinical outcome for the event of extremely high blood glucose level was unknown. The Pharmacist stated that she believed that this increase in blood glucose level was because of PREVNAR. Follow-up (03SEP2015): Follow-up attempts completed. No further information expected.
Information has been received from a physician and a nurse practitioner concerning a 9 yr old male who on 04Dec96, at one year of age, was vaccinated one time SC with a 0.5ml dose of varicella virus vaccine live (lot 620614/1106D). There was no concomitant medication. On 25Apr05 the pt was seen in the physician's office with varicella lesions primarily on the trunk and also around the eyes. The physician reported that a varicella test was performed. The pt fully recovered with no treatment at one week. No product quality complaint was involved. Additional information is not expected.
Shingrix only adjuvant administration; Shingrix only adjuvant administration; This case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a patient who received Herpes zoster (Shingrix) (batch number 34EC5, expiry date 2nd July 2024) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.       Additional Information: GSK Receipt Date: 27-FEB-2023 Reporter's Comment: The reporter was a nurse. The reporter reported that the box of Shingrix vaccine had an extra antigen vial so they assumed that one patient might received only the adjuvant of the Shingrix vaccine. The reporter did consent to follow up. Additional supportive information: The reporter stated that only adjuvant of shingrix vaccine administered to patient, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.
swelling over my left clavicle; having some swelling over my left clavicle, two lymph nodes; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received BNT162B2 (lot number: EK5730), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. After patient had a COVID vaccine, a reaction and patient even didn't if it was a reaction, patient was having some swelling over the left clavicle, two lymph nodes which the doctor did analyze. And it was (incomplete sentence), they were not certain with etiology where it was coming from. Patient was supposed to have the second shot this Tuesday, 12Jan2021 (later confirmed) and was a little eerie to have it because of that. Outcome of the events was unknown.
pt received covid vaccine on 6/8, itching to arms/hands began on 6/10 early morning and then intermittently throughout the day since then pt notices a red itchy rash to the b/l arms, lips, and torso.  Rash and itching has not resolved, it still occurs intermittently throughout the day.  Pt was advised to use benadryl, claritin and prescribed triamcinolone acetonide 0.1%  cream.
Site of injection swelled two times as large as normal. Site became hot and bruised. Child felt sick to her stomic and had a headache.
Initial report received from a registered nurse on Sept 28 2005, A 51 year old female patient developed a cough, fever and wheezing latency not reported which required hospitalization after receiving the injection of Adacel, lot number C2151AC and Fluzone, lot number U1854AA in the deltoid. Administration date, route and site not reported.  The patient has no known allergies and has a history of heart condition type unknown. She denies any illness at the time of vaccination and was on other medications, however the specific Meds are not known. It was reported that the patient was in the hospital for a week. Dates of hospitalization and treatment received not reported. As per reporter the patient was still hospitalized at the time of this report.
slight aggravation of allergy type symptoms (congestion, sneezing, itchy eyes); slight aggravation of allergy type symptoms (congestion, sneezing, itchy eyes); slight aggravation of allergy type symptoms (congestion, sneezing, itchy eyes); slight aggravation of allergy type symptoms (congestion, sneezing, itchy eyes); slight aggravation of allergy type symptoms (congestion, sneezing, itchy eyes); This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number and Expiration Date: not reported),via an unspecified route of administration, administered in left arm on 22Jan2021 at 10:15 (at the age of 42 years old) as dose 1, single for COVID-19 immunisation in a Pharmacy or Drug Store. Medical history included asthma, ITP (immune thrombocytopenic purpura), autoimmune neutropenia, allergies to animal dander, dust, sulfa and kiwi - all from an unknown date. The patient previously given ceftriaxone (ROCEFIN) and ciprofloxacin and experienced allergy. The patient was not pregnant at time of vaccination and prior to vaccination the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines in 4 weeks prior to the COVID vaccine. The patient has a list of other medications received in 2 weeks of vaccination. On 25Jan2021, the patient experienced slight aggravation of allergy type symptoms (congestion, sneezing, itchy eyes) 2 days after vaccine was given. The adverse events resulted to Doctor or other healthcare professional office/clinic visit. Treatment was given as response to the events which included unspecified allergy eye drops and inhaler. Since vaccination, the patient has not been tested for COVID-19. Outcome of all events was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Also she got COVID and she was pretty sick; Also she got COVID and she was pretty sick; Losing hair; Having an itchy and dry scalp; Having an itchy and dry scalp; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient got the COVID vaccine and was losing a lot of hair and also, she got COVID and she was pretty sick. The patient also had itchy and dry scalp. Outcome of the events was unknown.   Information on the batch/lot number has been requested.
3/17/21 Pt presented to ED w/ a 4-5 day history of cough, SOB, chills, fever and poor appetite.  Nasal swab + for SARS-CoV-2. CTA of chest showed pneumonia. He received on dose of Rocephin and azithromycin in ED. ATB discontinued upon admission to the hospital. Because of risk factors, patient was treated with bamlanivimab infusion. He was discharged to home on 3/19. At no time did he require oxygen.
12 days post vax the pt developed a couple of raised areas at the injection site that looked like mosquito bites. He sought unspecified medical attention. No further information is available. Follow up states patient recovered 02/07/2000.
INCREASED HEART RATE; MUSCLE ACHE; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on MAR-2021 for prophylactic vaccination. Batch number was not reported has been requested No concomitant medications were reported. On an unspecified date, the subject experienced increased heart rate, and muscle ache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from muscle ache, and increased heart rate. This report was non-serious.; Sender's Comments: V0:  Medical Assessment comment not required as per standard procedure as the case assessed as non-serious.
Child received immunizations 10/30/2001. Awake most of night, crying also had fever.
soreness/stinging at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (soreness/stinging at the injection site) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (soreness/stinging at the injection site). At the time of the report, VACCINATION SITE PAIN (soreness/stinging at the injection site) had resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No Concomitant use were reported.  No Treatment were reported.   This case was linked to MOD-2021-079424 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-Jan-2022: Follow up received on 06-JAN-2022: New event (suspected COVID-19) added. Corresponding fields and narrative updated accordingly.
Patient was given Yellow Fever vaccine on Right Arm followed by Pfizer bivalent booster on the Left Arm. We were discussing oral Typhoid vaccine and she stated she was feeling light-headed. Her mother remarked she her face was very pale. Patient was sitting in a chair and slumped over. I believe she experienced vasovagal syncope. She remained seated after coming out of it. Unfortunately, she did lose control of her bladder as she came out of it. Mom stated her daughter had never fainted before with vaccines. She remained seated and drank a Capri Sun. She was feeling better when they left. 2/6/2023 9:00 am. Follow up call to mom-mom states her daughter did have a sore arm where Pfizer bivalent had been given. She also reports her daughter had 3 bloody noses the next day on 2/4/2023.
Diagnosed with rare form of cancer; This spontaneous case was reported by a consumer and describes the occurrence of NEOPLASM MALIGNANT (Diagnosed with rare form of cancer) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced NEOPLASM MALIGNANT (Diagnosed with rare form of cancer) (seriousness criterion medically significant). At the time of the report, NEOPLASM MALIGNANT (Diagnosed with rare form of cancer) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       No concomitant medications were reported.  "This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in."  No treatment information was reported.  Company Comment: This is a spontaneous case concerning a female patient of unknown age with no reported medical history, who experienced the unexpected, serious (medically significant) event of Neoplasm malignant(reported as rare form of cancer), approximately 1 month after receiving a dose of mRNA-1273 vaccine. Clinical course, diagnostic tests and treatment details were not provided in the case. The outcome of the event was unknown at the time of the report. The benefit-risk relationship of mRNA-1273 is not affected by this report.    Reporter did not allow further contact; Sender's Comments: This is a spontaneous case concerning a female patient of unknown age with no reported medical history, who experienced the unexpected, serious (medically significant) event of Neoplasm malignant(reported as rare form of cancer), approximately 1 month after receiving a dose of mRNA-1273 vaccine. Clinical course, diagnostic tests and treatment details were not provided in the case. The outcome of the event was unknown at the time of the report. The benefit-risk relationship of mRNA-1273 is not affected by this report.
She got her vaccine, other than making her fatigue and tired she was doing okay.  6 days later at 2:00 AM she needed to use the bathroom, and when she got up she saw that she was not able to go back to sleep as she was too alert.  She noticed that her heart was pounding, she was not experiencing chest pain, shortness of breath, but her heart was incredibly beat.  Her fit-bit showed that her heart rate was 120-130, her BP was extremely high and she decided to go to the ER, which pulse was over double of what is usual for her.  They took her BP in the ER and it was 80-90s, and her pulse was 80-90s, and the BP was then high normals.  They asked her if she wanted to stay, she wanted to go home and go back to sleep and did, and went to see her PCP.  They had a record of her being seen but not being processed.  Between that and had her annual x-ray which came back with a mild enlargement of her heart, which she did not have the year before.  Her GP and with her family history of her father having heart blockage he recommeded she see a cardiologist.  She made an apponitment, she saw him on 11/2/23.  Then she saw him on that day, they did an EKG and did not show an issue, and they did not mention anything, but made an apponitment for a stree test, echo, calcium test in december.  On Sunday morning 11/5/23 she woke up at 4:00 PM that a dream that she was having labor.  She got up and went to the bathroom and noticed that she was having the same thing again, heart racing, and was going from 129-150, 160 and topped out at 180 bpm.  She went to the ER again for the same problem.  She is dressed for work, and got to the ER at 6:00 AM and walked in and did have her oxygen meter and it was all over the place.  She walked in and her pulse was 154, no chest pain or shortness of breath.  At registration it was 132, and 90 again.  Her BP was in 144/60's.  She decided to have the cardiac work up because this time her pulse was down to 67.  They did the troponin's and it took over 7 hours to complete.  After 4 tests her troponin's had climbed and she was admitted to the hospital.  They got her checked in by about 3:30-4:30 PM.  By that time she had told her husband that she was there, and other than monitoring her they set her up with tests.  She got an Echo, they did her rounds and her cardiologist was doing rounds, and all the tests were expedited that she was going to have in December.  They did a heart cath and her BP dropped 20 points when she found out she did not have any blockages.  They went through the radial artery in her wrist, and they had the pressure on it for an hour or so and checked her VS, and continued to monitor her wrist and hand.    The next morning she did not see any doctors, they talked to her cardiologist and said that she could be released and she got out on 11/7/23.  She saw her GP on Thursday and he said that everything sounded good, and she got a referral for sleep apnea.  She has an appointment in december for that.  She was on a heart monitor while she was in the hospital again.  She is going to be put on a heart monitor for 2 weeks starting tomorrow.  She has fear to go to sleep wondering if this is going to happen again.
I had vaccination on 09/26/2022. I woke up feeling achy on 10/02/2022 with a lot of congestion and post nasal drip. It progressed and started to go into my respiratory area with burning feeling. It was painful on back where lungs are located with shortness of breath. I did a COVID-19 test at home and it was positive. I contacted the doctor on 10/5/2022. They prescribed PAXLOVID. I have tested COVID-19 negative on 10/22/2022. I am starting to have cold like symptoms and will retest for COVID.
Fever, headache, diarrhea, severe pain on my (Rt) leg, Rt. lumbar pain, swelling of the (Rt) wrist and unable to walk for 3 weeks or more, unable to use the (Rt) hand to write for more than 30 minutes or lift a heavy object up till now, tendonitis, chest pain initially.
This spontaneous report as received from a pharmacist refers to a 60 year old female patient. The patient had drug reaction/allergy for penicillin. Pertinent medical history not reported. On 13-JAN-2014 the patient was vaccinated with ZOSTAVAX (lot # J011338, exp. date: 19-DEC-2014, single dose, subcutaneous injection in the right arm) for vaccination. No concomitant therapies reported> on 15-JAN-2014 the patient developed redness, warmth, swelling, and itching at the injection site on the right arm. The patient also developed right arm pain and tingling of the fingers. The patient sought medical attention via pharmacy visit. No treatment was given. The outcome of events was not recovered. The relatedness between ZOSTAVAX and events was not reported. Additional information is not expected.
pt recv vax; sudden death; pale, grunting at home; expired w/in mins p/ moaning; arrived to er in asystole;
Skin reaction in the local area, redness, peeling of skin. Asthma flare up.
I having rapid heart rhythm or Tachycardia. This has been going on since Nov 29th. I went to my cardiologist about this. I am scheduled to have an EKG on Jan 6th.
Haven't seen a place to leave this so I'll say I had covid in November.  Started tired at 2 30, but 20 minutes later had a 101.4 fever (peaked at 102,) headache, joint ache over my entire body, cloudy thinking.  Went to bed 8 hours later and was gone when I woke up. Arm no longer sore either.
Moderate rash and/or hives (unsure) flaring up on both hands this last week and now spreading to wrist and fingers. The bumps itch and then swell and then go back down and then flare up again.  Benadryl has been taken with little relief. As well as applying hydrocortisone liberally. No other rash/hives have appeared anywhere else on my body.
A report was received from a health care professional on 10/20/2003 concerning a 54 year old female vaccinee who experienced a red, hard, swollen area on day after receiving Fluvirin on 10/15/2003. On 10/16/2003, the vaccinee experienced a red, hard, swollen area about 2 inches in diameter after receiving Fluvirin on 10/15/2003. the event resolved after 2 days. There was insufficient information to determine the reporter's causality assessment. Follow up pending. Reference: PJP-2003-00833, PJP-2003-00834, PJP-2003-00836
many discreet 2-4mm maculopapules very erythematous throughout chest & back also scattered on arms & legs-much more discreet & inflammatory appearing w/fever last 5 days;